Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. more
Time Frame | SRRK | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.95% | -3.39% | 0.2% |
1-Month Return | 65.47% | -1.92% | 2.72% |
3-Month Return | 429.73% | -10.54% | 7.31% |
6-Month Return | 397.15% | -4.47% | 10.44% |
1-Year Return | 143.18% | 4.06% | 27.53% |
3-Year Return | 73.7% | 0.94% | 30.88% |
5-Year Return | 280.23% | 36.67% | 89.21% |
10-Year Return | 181.61% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 20.49M | 15.40M | 18.82M | 33.19M | - | [{"date":"2019-12-31","value":61.74,"profit":true},{"date":"2020-12-31","value":46.4,"profit":true},{"date":"2021-12-31","value":56.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 54.22M | 74.06M | 9.02M | 9.88M | 2.84M | [{"date":"2019-12-31","value":73.2,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":12.18,"profit":true},{"date":"2022-12-31","value":13.35,"profit":true},{"date":"2023-12-31","value":3.84,"profit":true}] |
Gross Profit | 20.49M | 15.40M | 9.79M | 33.19M | (2.84M) | [{"date":"2019-12-31","value":61.74,"profit":true},{"date":"2020-12-31","value":46.4,"profit":true},{"date":"2021-12-31","value":29.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-8.57,"profit":false}] |
Gross Margin | 100.00% | 100.00% | 52.04% | 100.00% | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 75.03M | 102.28M | 148.74M | 167.56M | 171.29M | [{"date":"2019-12-31","value":43.8,"profit":true},{"date":"2020-12-31","value":59.71,"profit":true},{"date":"2021-12-31","value":86.83,"profit":true},{"date":"2022-12-31","value":97.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (54.54M) | (86.88M) | (129.92M) | (134.37M) | (171.29M) | [{"date":"2019-12-31","value":-5454200000,"profit":false},{"date":"2020-12-31","value":-8687800000,"profit":false},{"date":"2021-12-31","value":-12992100000,"profit":false},{"date":"2022-12-31","value":-13437000000,"profit":false},{"date":"2023-12-31","value":-17129500000,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (51.00M) | (86.48M) | (131.80M) | (134.50M) | (165.79M) | [{"date":"2019-12-31","value":-5100000000,"profit":false},{"date":"2020-12-31","value":-8648300000,"profit":false},{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13450200000,"profit":false},{"date":"2023-12-31","value":-16578900000,"profit":false}] |
Income Taxes | (1.30M) | (1.49M) | 2.39M | (2.85M) | 2.68M | [{"date":"2019-12-31","value":-48.69,"profit":false},{"date":"2020-12-31","value":-55.72,"profit":false},{"date":"2021-12-31","value":89.33,"profit":true},{"date":"2022-12-31","value":-106.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (51.00M) | (86.48M) | (131.80M) | (134.50M) | (158.92M) | [{"date":"2019-12-31","value":-5100000000,"profit":false},{"date":"2020-12-31","value":-8648300000,"profit":false},{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13450200000,"profit":false},{"date":"2023-12-31","value":-15891800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (49.70M) | (84.99M) | (131.80M) | (131.65M) | (165.79M) | [{"date":"2019-12-31","value":-4969700000,"profit":false},{"date":"2020-12-31","value":-8499200000,"profit":false},{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13164800000,"profit":false},{"date":"2023-12-31","value":-16578900000,"profit":false}] |
EPS (Diluted) | (1.85) | (2.81) | (3.59) | (2.28) | (1.99) | [{"date":"2019-12-31","value":-185,"profit":false},{"date":"2020-12-31","value":-281,"profit":false},{"date":"2021-12-31","value":-359,"profit":false},{"date":"2022-12-31","value":-228,"profit":false},{"date":"2023-12-31","value":-199,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SRRK | |
---|---|
Cash Ratio | 3.53 |
Current Ratio | 3.88 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SRRK | |
---|---|
ROA (LTM) | -67.10% |
ROE (LTM) | -183.07% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SRRK | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.56 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.44 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SRRK | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 13.14 |
P/B | 50.68 |
Price/FCF | NM |
EV/R | 8.22 |
EV/Ebitda | NM |
Scholar Rock Holding Corp (SRRK) share price today is $41.65
Yes, Indians can buy shares of Scholar Rock Holding Corp (SRRK) on Vested. To buy Scholar Rock Holding Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SRRK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Scholar Rock Holding Corp (SRRK) via the Vested app. You can start investing in Scholar Rock Holding Corp (SRRK) with a minimum investment of $1.
You can invest in shares of Scholar Rock Holding Corp (SRRK) via Vested in three simple steps:
The 52-week high price of Scholar Rock Holding Corp (SRRK) is $46.19. The 52-week low price of Scholar Rock Holding Corp (SRRK) is $6.76.
The price-to-earnings (P/E) ratio of Scholar Rock Holding Corp (SRRK) is
The price-to-book (P/B) ratio of Scholar Rock Holding Corp (SRRK) is 50.68
The dividend yield of Scholar Rock Holding Corp (SRRK) is 0.00%
The market capitalization of Scholar Rock Holding Corp (SRRK) is $4.09B
The stock symbol (or ticker) of Scholar Rock Holding Corp is SRRK